Medical Affairs & Information Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sarepta Therapeutics · 6 hours ago

Medical Affairs & Information Intern

Sarepta Therapeutics is a leader in genetic medicine, focusing on Duchenne muscular dystrophy and other diseases. The Medical Affairs & Information Summer Intern will support the Medical Affairs and Medical Information teams by enhancing scientific reference systems and improving operational capacity during a high-demand period.

BiotechnologyGeneticsHealth CareTherapeutics
check
Growth Opportunities
badNo H1Bnote

Responsibilities

Improving the structure and accuracy of reference content within Veeva Vault Medical
Enhancing the Literature Alert Bulletin and supporting literature search processes
Assisting in streamlining reporting for Medical Information and review activities
Supporting Medical Affairs initiatives such as call center insights, metrics, training, and audit readiness

Qualification

Veeva Vault MedicalScientific literature analysisMedical Affairs knowledgeProactive attitudeCuriosityAttention to detailOrganizational skillsWritten communicationVerbal communication

Required

Currently pursuing a bachelor's degree in life sciences, pharmacy, biomedical sciences, public health, or a related field
Interest in Medical Affairs, Medical Information, or scientific communications
Strong attention to detail and organizational skills
Ability to analyze scientific literature and summarize key findings
Comfortable working in databases or content management systems (experience with Veeva Vault is a plus but not required)
Excellent written and verbal communication skills
Proactive, curious, and eager to learn in a fast-paced environment

Benefits

Competitive compensation and benefit package

Company

Sarepta Therapeutics

company-logo
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.

Funding

Current Stage
Public Company
Total Funding
$2.88B
Key Investors
Michael Andrew ChambersPharmakon AdvisorsMidCap Financial
2025-12-11Post Ipo Debt· $291.4M
2025-08-21Post Ipo Equity
2025-08-21Post Ipo Debt· $602M

Leadership Team

leader-logo
Ian Estepan
Executive Vice President, Chief Financial Officer
linkedin
K
Kathy Behrens Wilsey
Director
linkedin
Company data provided by crunchbase